Imagion Biosystems Competitors

(BUX) (CNSX:BUX) and Imagion Biosystems (ASX:IBX) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Earnings & Valuation

This table compares (BUX) and Imagion Biosystems' top-line revenue, earnings per share and valuation.

(BUX) has higher earnings, but lower revenue than Imagion Biosystems.

Profitability

This table compares (BUX) and Imagion Biosystems' net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for (BUX) and Imagion Biosystems, as provided by MarketBeat.com.

Summary

Imagion Biosystems beats (BUX) on 1 of the 1 factors compared between the two stocks.

12144 (CNSX:IME) and Imagion Biosystems (ASX:IBX) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

Earnings and Valuation

This table compares 12144 and Imagion Biosystems' top-line revenue, earnings per share and valuation.

12144 has higher earnings, but lower revenue than Imagion Biosystems.

Profitability

This table compares 12144 and Imagion Biosystems' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current recommendations and price targets for 12144 and Imagion Biosystems, as provided by MarketBeat.

Summary

Imagion Biosystems beats 12144 on 1 of the 1 factors compared between the two stocks.

Imagion Biosystems (ASX:IBX) and BARD1 Life Sciences (ASX:BD1) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, risk, dividends and valuation.

Valuation and Earnings

This table compares Imagion Biosystems and BARD1 Life Sciences' revenue, earnings per share (EPS) and valuation.

BARD1 Life Sciences has lower revenue, but higher earnings than Imagion Biosystems.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Imagion Biosystems and BARD1 Life Sciences, as provided by MarketBeat.com.

Profitability

This table compares Imagion Biosystems and BARD1 Life Sciences' net margins, return on equity and return on assets.

Summary

Imagion Biosystems beats BARD1 Life Sciences on 2 of the 3 factors compared between the two stocks.

Charles River Laboratories International (CNSX:CRL) and Imagion Biosystems (ASX:IBX) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation.

Valuation and Earnings

This table compares Charles River Laboratories International and Imagion Biosystems' revenue, earnings per share and valuation.

Charles River Laboratories International has higher earnings, but lower revenue than Imagion Biosystems.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Charles River Laboratories International and Imagion Biosystems, as provided by MarketBeat.

Profitability

This table compares Charles River Laboratories International and Imagion Biosystems' net margins, return on equity and return on assets.

Summary

Imagion Biosystems beats Charles River Laboratories International on 1 of the 1 factors compared between the two stocks.

Imagion Biosystems (ASX:IBX) and Cryosite (ASX:CTE) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings and dividends.

Valuation & Earnings

This table compares Imagion Biosystems and Cryosite's top-line revenue, earnings per share (EPS) and valuation.

Cryosite has higher revenue and earnings than Imagion Biosystems.

Analyst Ratings

This is a breakdown of current ratings for Imagion Biosystems and Cryosite, as reported by MarketBeat.com.

Profitability

This table compares Imagion Biosystems and Cryosite's net margins, return on equity and return on assets.

Summary

Cryosite beats Imagion Biosystems on 3 of the 3 factors compared between the two stocks.

Imagion Biosystems (ASX:IBX) and dorsaVi (ASX:DVL) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Valuation and Earnings

This table compares Imagion Biosystems and dorsaVi's top-line revenue, earnings per share (EPS) and valuation.

dorsaVi has lower revenue, but higher earnings than Imagion Biosystems.

Profitability

This table compares Imagion Biosystems and dorsaVi's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Imagion Biosystems and dorsaVi, as reported by MarketBeat.

Summary

Imagion Biosystems beats dorsaVi on 2 of the 3 factors compared between the two stocks.